Decoy Therapeutics Inc. (DCOY) stock
DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.95+0.05 (+5.37%)
Close on Nov 17, 2026Market cap $622.03KP/E –Yield –
Decoy Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Decoy Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$8.32M. For fiscal 2025 it was -$4.83M. The highest annual figure on record is $4.18M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.83M | – |
| FY2024 | Dec 31, 2024 | -$4.53M | – |
| FY2023 | Dec 31, 2023 | -$12.85M | – |
| FY2022 | Dec 31, 2022 | -$17.60M | – |
| FY2021 | Dec 31, 2021 | -$10.20M | – |
| FY2020 | Dec 31, 2020 | -$10.31M | – |
| FY2019 | Dec 31, 2019 | -$11.58M | -377.2% |
| FY2018 | Dec 31, 2018 | $4.18M | – |
| FY2017 | Dec 31, 2017 | -$27.72M | – |
| FY2016 | Dec 31, 2016 | -$32.05M | – |
| FY2015 | Dec 31, 2015 | -$20.75M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.89M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.14M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.65M | – |
| Q2 FY2025 | Jun 30, 2025 | -$862.30K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.18M | – |
| Q4 FY2024 | Dec 31, 2024 | -$742.52K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.36M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.07M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.35M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.51M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.75M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.42M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.17M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.71M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.74M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.62M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.52M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.72M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.17M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.72M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.37M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.75M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.48M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.71M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.64M | -780.3% |
| Q3 FY2019 | Sep 30, 2019 | -$5.54M | -125.8% |
| Q2 FY2019 | Jun 30, 2019 | -$1.53M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.87M | – |
| Q4 FY2018 | Dec 31, 2018 | $387.54K | – |
| Q3 FY2018 | Sep 30, 2018 | $21.46M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.26M | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.41M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.76M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.05M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.69M | – |
| Q1 FY2017 | Mar 31, 2017 | -$8.23M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.30M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.25M | – |
See a number that looks wrong?